TransCode Therapeutics (RNAZ) Institutional Ownership $10.46 -0.92 (-8.08%) Closing price 09/23/2025 04:00 PM EasternExtended Trading$10.55 +0.09 (+0.87%) As of 04:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for TransCode Therapeutics (NASDAQ:RNAZ)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$563.55MNumber ofInstitutional Sellers(last 12 months)0 Get RNAZ Insider Trade Alerts Want to know when executives and insiders are buying or selling TransCode Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RNAZ Institutional Buying and Selling by Quarter TransCode Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/28/2025Anson Funds Management LP1,462,112$724K0.1%N/A175.524% 5/14/2025Anson Funds Management LP1,462,112$724K0.1%N/A6.264% 5/9/2025Warberg Asset Management LLC50,000$25K0.0%N/A0.214% 11/1/2024Sheets Smith Wealth Management50,138$29K0.0%+149.0%0.290% 5/20/2024Virtu Financial LLC55,329$37K0.0%N/A0.836% 11/15/2023Sabby Management LLC250,309$126K0.1%+32.8%12.330% 4/21/2022K.J. Harrison & Partners Inc19,987$58K0.0%+24.9%0.155% 2/4/2022Redmond Asset Management LLC88,010$224K0.1%N/A0.682% 1/26/2022K.J. Harrison & Partners Inc16,000$41K0.0%N/A0.124% 11/16/2021ACT Capital L.L.C.50,000$150K0.1%N/A0.387% 11/16/2021National Asset Management Inc.25,000$75K0.0%N/A0.194% 11/16/2021Two Sigma Securities LLC33,314$100K0.0%N/A0.258% 11/12/2021AIGH Capital Management LLC1,270,500$3.80M0.8%N/A9.845% (Data available from 1/1/2016 forward) RNAZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAZ shares? During the previous two years, the following institutional investors and hedge funds held shares of TransCode Therapeutics shares: Anson Funds Management LP ($724K), Sabby Management LLC ($126K), Virtu Financial LLC ($37K), and Sheets Smith Wealth Management ($29K), Warberg Asset Management LLC ($25K).Learn more on TransCode Therapeutics' institutional investors. Which institutional investors have been buying TransCode Therapeutics' stock? The following institutional investors have purchased TransCode Therapeutics' stock in the last 24 months: Anson Funds Management LP ($2.92M), Sabby Management LLC ($61.87K), Virtu Financial LLC ($55.33K), Warberg Asset Management LLC ($50K), and Sheets Smith Wealth Management ($30K). How much institutional buying is happening at TransCode Therapeutics? Institutional investors have bought a total of 3,004,224 shares in the last 24 months. This purchase volume represents approximately $563.55M in transactions. Related Companies Mersana Therapeutics Institutional Ownership Senti Biosciences Institutional Ownership Dyadic International Institutional Ownership Renovaro Institutional Ownership OnKure Therapeutics Institutional Ownership Iterum Therapeutics Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Kezar Life Sciences Institutional Ownership Dare Bioscience Institutional Ownership CASI Pharmaceuticals Institutional Ownership This page (NASDAQ:RNAZ) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAZ Stock Alerts